Ian Sanne to Developing Countries
This is a "connection" page, showing publications Ian Sanne has written about Developing Countries.
Connection Strength
0,527
-
Research as a path to wide-scale implementation of antiretroviral therapy in Africa. J HIV Ther. 2004 Sep; 9(3):65-8.
Score: 0,190
-
Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa. Int J Tuberc Lung Dis. 2013 Mar; 17(3):368-72.
Score: 0,085
-
Differences in normal activities, job performance and symptom prevalence between patients not yet on antiretroviral therapy and patients initiating therapy in South Africa. AIDS. 2008 Jul; 22 Suppl 1:S131-9.
Score: 0,062
-
Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. J Acquir Immune Defic Syndr. 2007 Sep 01; 46(1):91-100.
Score: 0,058
-
Hard choices: rationing antiretroviral therapy for HIV/AIDS in Africa. Lancet. 2005 Jan 22-28; 365(9456):354-6.
Score: 0,048
-
Challenges in delivering antiretroviral treatment in resource poor countries. AIDS. 2002; 16 Suppl 4:S177-87.
Score: 0,039
-
International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271. J Neurovirol. 2016 08; 22(4):472-8.
Score: 0,026
-
Xpert(®) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? Expert Rev Mol Diagn. 2010 Oct; 10(7):937-46.
Score: 0,018